| Martinez, Francisco E |
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) |
|
|
| Recruiting | 2 | 320 | Europe, Canada, Japan, US, RoW | TIN816 70 mg lyophilisate powder, Placebo | Novartis Pharmaceuticals | Acute Kidney Injury Due to Sepsis | 12/25 | 02/26 | | |
| Wunderink, Richard |
| Terminated | 3 | 409 | Europe, US, RoW | Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo | Dompé Farmaceutici S.p.A | Infectious Pneumonia, Severe COVID-19 | 09/24 | 09/24 | | |
NCT05947955: Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) |
|
|
| Recruiting | 2 | 600 | Europe, US | Rhu-pGSN, recombinant human gelsolin, normal saline, 0.9% sterile saline | BioAegis Therapeutics Inc., Biomedical Advanced Research and Development Authority | Acute Respiratory Distress Syndrome, Infections | 10/26 | 03/27 | | |
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) |
|
|
| Recruiting | 2 | 320 | Europe, Canada, Japan, US, RoW | TIN816 70 mg lyophilisate powder, Placebo | Novartis Pharmaceuticals | Acute Kidney Injury Due to Sepsis | 12/25 | 02/26 | | |
RESCUE3, NCT03783884: A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation |
|
|
| Terminated | N/A | 223 | Europe, US | Lungpacer Diaphragm Pacing Therapy, Lungpacer DPTS, AeroPace System | Lungpacer Medical Inc. | Ventilator Induced Diaphragm Dysfunction | 12/22 | 01/23 | | |
NCT04105699: Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis |
|
|
| Completed | N/A | 544 | US | Blood sampling | Abionic SA, Avania | Sepsis | 08/23 | 12/23 | | |
| Gee, Kayla Mc |
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) |
|
|
| Recruiting | 2 | 320 | Europe, Canada, Japan, US, RoW | TIN816 70 mg lyophilisate powder, Placebo | Novartis Pharmaceuticals | Acute Kidney Injury Due to Sepsis | 12/25 | 02/26 | | |
